-
Armas Pharmaceuticals Announces Launch of Oncology Generic Erlotinib
Post on 11/13/19
-
Risalto Health Raises $7M
Post on 11/13/19
-
Why Celgene's Latest FDA Approval Makes Bristol-Myers Squibb's Dividend Look Even Better
Post on 11/13/19
-
HealthCare.com Ranked Number 155 Fastest Growing Company in North America on Deloitte’s 2019 Technology Fast 500
Post on 11/12/19
-
Better Buy: Biogen vs. Celgene
Post on 11/12/19
-
Why Bristol-Myers Squibb Stock Gained 13% in October
Post on 11/12/19
-
Bioasis Completes Financing Transactions
Post on 11/11/19
-
Citius Pharmaceuticals Issues Corporate Update
Post on 11/8/19
-
Advocare Welcomes Seven New Independent Physician Practices
Post on 11/7/19
-
Zoetis Announces Third Quarter 2019 Results
Post on 11/7/19
-
Amneal Reports Third Quarter 2019 Financial Results
Post on 11/6/19
-
Enhanced Healthcare Partners and Bourne Partners Strategic Capital Announce Investment in Pharmaceutical Associates
Post on 11/6/19
-
Cara Therapeutics Reports Third Quarter 2019 Financial Results
Post on 11/6/19
-
Regeneron Pharmaceuticals Tops Q3 Estimates Thanks to Soaring Sales of 2 Drugs
Post on 11/6/19
-
Quest Diagnostics Earns Gold Status in American Heart Association's 2019 Workplace Health Achievement Index
Post on 11/5/19
-
pCare Partners with Redox
Post on 11/5/19
-
Innovative Management Solutions New York Partners with Arcadia.io
Post on 11/5/19
-
Intercept Pharmaceuticals Reports Third Quarter 2019 Financial Results and Provides Business Update
Post on 11/5/19
-
Antares Pharma Reports Third Quarter 2019 Operating and Financial Results
Post on 11/5/19
-
Amarin Reports Third Quarter 2019 Financial Results and Provides Update on Operations
Post on 11/5/19
-
Interview With Chaim Lebovits, CEO Of Brainstorm Cell Therapeutics
Post on 11/5/19
-
Cosette Pharmaceuticals Announces the Acquisition of G&W Laboratories' Lincolnton, NC Finished Dosage Manufacturing Plant
Post on 11/4/19
-
Amulet Capital’s OPEN Health Merges with Pharmerit International
Post on 11/4/19
-
Johnson & Johnson's Xarelto Gains Another FDA Approved Indication, Needs Additional Nods Under Its Belt
Post on 11/4/19
-
Ovid Therapeutics Announces Senior Management Promotions
Post on 11/3/19